PRESS RELEASE published on 02/21/2024 at 14:15, 2 years 6 months ago Biotricity Strengthens its Foundation for Growth, Achieves Lower Cost of Sales, Expanding Margins of 73% and Increased Device Sales, for Third Quarter of Fiscal Year 2024 Biotricity Inc. reports Q3FY24 financial results showing topline growth, increased subscription revenue, improved margins, lower costs, and a stronger path to breakeven in the remote cardiac monitor sector of consumer healthcare Healthcare Biotricity Inc. Q3FY24 Financial Results Subscription Revenue Remote Cardiac Monitor
BRIEF published on 02/21/2024 at 14:15, 2 years 6 months ago Biotricity Inc. announces growth with a significant increase in subscriptions for the third quarter of the 2024 fiscal year Financial Results Revenue Growth Biotricity Inc. Remote Cardiac Monitoring Technological Subscriptions
BRIEF published on 02/21/2024 at 14:15, 2 years 6 months ago Biotricity Inc. annonce une croissance avec une augmentation significative des abonnements pour le troisième trimestre de l'exercice 2024 Résultats Financiers Biotricity Inc. Croissance Des Revenus Surveillance Cardiaque À Distance Abonnements Technologiques
PRESS RELEASE published on 02/19/2024 at 14:00, 2 years 6 months ago Biotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21st Biotricity Inc. to host Third Quarter FY 2024 Financial Results and Business Update Call on February 21, 2024, featuring Founder Dr. Waqaas Al-Siddiq and CFO John Ayanoglou. Event details and webcast information provided Financial Results Business Update Biotricity Inc. Investor Call Remote Health Monitoring
PRESS RELEASE published on 02/14/2024 at 14:00, 2 years 6 months ago Biotricity Advances Towards Breakeven Milestone - Set to Announce Record Margins and Operational Efficiency for Third Quarter of Fiscal Year 2024 Biotricity Inc. continues its shift to subscription-based revenue, emphasizing margin improvement and operational efficiency enhancements. Company to announce Third Quarter Fiscal 2024 Results on February 20, 2024 Operational Efficiency Biotricity Inc. Subscription-based Revenue Margin Improvement Third Quarter Fiscal 2024 Results
PRESS RELEASE published on 01/23/2024 at 14:15, 2 years 7 months ago Biotricity Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion Heartbeats Biotricity Inc. (NASDAQ:BTCY) has announced the expansion of its Cardiac AI Cloud platform, aiming to develop predictive monitoring to identify issues before they occur, supporting earlier interventions, and reducing healthcare costs. The company's goal is to build comprehensive AI models for improved diagnoses and interventions, having analyzed over 360 billion heartbeats and helped diagnose over 200,000 patients. The development of large data models is crucial for supporting the intermittent nature of cardiac issues and the noisy data arising from ambulatory monitoring, and for helping cardiologists service more patients. The company's effort in building a comprehensive Cardiac AI Cloud platform aims to make cardiac care accessible, affordable, and scalable, thus providing necessary support and assistance to healthcare professionals. For more information, visit www.biotricity.com. Biotricity Inc. Cardiac AI Cloud Platform Predictive Monitoring Healthcare Costs Comprehensive AI Models
Published on 09/11/2026 at 04:00, 8 hours 38 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 14 hours 13 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 21 hours 18 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 21 hours 38 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:43, 55 minutes ago Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 1 hour 2 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 1 hour 8 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 2 hours 23 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 07:00, 5 hours 38 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 5 hours 38 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 5 hours 38 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 17 hours 8 minutes ago Availability of the 2026 Interim Financial Report